Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe.
Szymańska K, Moore LE, Rothman N, Chow WH, Waldman F, Jaeger E, Waterboer T, Foretova L, Navratilova M, Janout V, Kollarova H, Zaridze D, Matveev V, Mates D, Szeszenia-Dabrowska N, Holcatova I, Bencko V, Le Calvez-Kelm F, Villar S, Pawlita M, Boffetta P, Hainaut P, Brennan P. Szymańska K, et al. Among authors: villar s. Cancer Lett. 2010 Jul 1;293(1):92-8. doi: 10.1016/j.canlet.2009.11.024. Epub 2010 Feb 6. Cancer Lett. 2010. PMID: 20137853
TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America.
Szymańska K, Levi JE, Menezes A, Wünsch-Filho V, Eluf-Neto J, Koifman S, Matos E, Daudt AW, Curado MP, Villar S, Pawlita M, Waterboer T, Boffetta P, Hainaut P, Brennan P. Szymańska K, et al. Among authors: villar s. Carcinogenesis. 2010 Jun;31(6):1054-9. doi: 10.1093/carcin/bgp212. Epub 2009 Dec 2. Carcinogenesis. 2010. PMID: 19955396
Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia.
Simoes C, Gonzalez C, Vergez F, Sarry A, Bertoli S, Ariceta B, Martínez-Cuadrón D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez-Lorenzo JL, Vidriales MB, Chillon C, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MÁ, Récher C, Paiva B, Montesinos P; PETHEMA Cooperative Study Group. Simoes C, et al. Among authors: villar s. Blood Neoplasia. 2024 Jun 19;1(3):100027. doi: 10.1016/j.bneo.2024.100027. eCollection 2024 Sep. Blood Neoplasia. 2024. PMID: 40453058 Free PMC article. No abstract available.
Progressive Multifocal Leukoencephalopathy (PML) after hematopoietic cell transplantation (HCT): a retrospective study of Infectious Diseases Working Party (IDWP) of the EBMT.
Dybko J, Szlasa W, Gil L, Wendel L, Tridello G, Knelange N, Kröger N, Hayat A, Liga M, Blijlevens N, Bazarbachi A, Faraci M, Ganser A, Steinhardt M, Gruhn B, Stamouli M, Villar S, Passweg J, Schots R, Bernasconi P, Zuckerman T, Mikulska M, Averbuch D, de la Camara R, Styczyński J. Dybko J, et al. Among authors: villar s. Bone Marrow Transplant. 2025 May 28. doi: 10.1038/s41409-025-02635-w. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 40437046 No abstract available.
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis.
Villar S, Curis E, Schlageter MH, Bosselut N, Charbonnier A, Rubio MT, Turlure P, Labussière H, Bay JO, Cornillon J, Vincent L, Orvain C, Kiladjian JJ, Michonneau D, Socié G, Robin M. Villar S, et al. Cancer Immunol Immunother. 2025 Apr 24;74(6):181. doi: 10.1007/s00262-025-04046-8. Cancer Immunol Immunother. 2025. PMID: 40274649 Free PMC article.
254 results